MIMEDX, INC.

Company News

Mimedx Provides Update on Previously Announced Senior Executive Separations

Board and Compensation Committee Determine That Separations Be Treated as "For Cause" Terminations Based on Information from Audit Committee's Ongoing Independent Investigation Parker H. Petit Resigns as Member of MiMedx Board, Effective Immediately MARIETTA, Ga., Sept. 20, 2018 /PRNewswire/ -- The Board of Directors (the "Board") of MiMedx Group, Inc. (Nasdaq: MDXG), a leading developer...

Read More »
Company News

MiMedx to Present at 36th Annual J.P. Morgan Healthcare Conference

MARIETTA, Ga., Jan. 2, 2018 - MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare, announced today that it will present at the 36th Annual J.P. Morgan Healthcare Conference. Parker H. "Pete" Petit,...

Read More »
Company News

MiMedx Agrees to Lawsuit Settlement with Former Employee

MARIETTA, Ga., Dec. 19, 2017 - MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today that the Company has agreed to a confidential lawsuit settlement from one former employee. MiMedx has...

Read More »

All Topics